Tempers Flare At ODAC Meeting, And Pazdur Must Call "Order In The Court"

Tempers frayed as the FDA Oncologic Drugs Advisory Committee gathered to review GlaxoSmithKline's Avodart (dutasteride) and Merck's Proscar (finasteride) for prostate cancer prevention Dec. 1.